StonvexLoading…
StonvexStonvexStonvexCore line items from EVCM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $155.27M | $147.47M | $588.91M | $437.75M | $290.29M |
Operating Income | Not available | $12.58M | $59.25M | $45.96M | $30.01M |
Net Income | Not available | $7.17M | $17.60M | $11.56M | $8.15M |
EPS (Diluted) | $0.17 | $0.04 | $0.10 | $0.06 | $0.00 |
Total Assets | Not available | $1.37B | $1.37B | $1.40B | $1.42B |
Total Liabilities | Not available | $654.31M | $654.92M | $674.59M | $675.03M |
Cash & Equivalents | Not available | $129.32M | $129.73M | $106.90M | $151.06M |
Free Cash Flow OCF − CapEx | Not available | $23.75M | $109.23M | $88.25M | $56.67M |
Shares Outstanding | Not available | 177.25M | 178.11M | 180.04M | 182.19M |